Chelation therapy is based on the principle that drugs that bind metal ions facilitate their elimination from the body. The form of EDTA, the target metal, the dose, and the route of administration are critically important for safety.
Use in toxicology
Chelation may be used in certain confirmed cases of heavy metal poisoning following a toxicological evaluation. Diagnosis is not based solely on symptoms or unvalidated device measurements; it is supported by an exposure history and appropriate biological tests.
Role in cardiovascular diseases
TACT2, conducted following the findings of the initial TACT study, showed that EDTA chelation did not reduce cardiovascular events in people with diabetes and a previous heart attack. A reduction in blood lead levels did not mean a reduction in heart attacks or strokes. Therefore, EDTA should not be presented as a routine “artery-opening” treatment for coronary disease and should not be used in place of standard treatments.
How is the need for chelation determined?
Vague complaints or the phrase “toxin burden” alone are not an indication for chelation. Unnecessary administration can also bind beneficial minerals and lead to serious complications.
Safety
Kidney damage, hypocalcemia, arrhythmia, a drop in blood pressure, and mineral imbalances may develop. In particular, the wrong form of EDTA or rapid infusion can be life-threatening. Kidney function, electrolytes, and medications being used should be closely monitored.
Frequently asked questions
How is treatment appropriate for the target metal selected?
The appropriate chelator differs for each metal; the wrong agent may be ineffective or harmful.
What is the first step in the event of exposure?
The priority is to identify the source of exposure and prevent contact. The decision to use chelation is based on appropriate tests, symptoms, and a toxicological evaluation; it is not routinely administered for general prevention.
Related content
You can learn about IV treatments and our approach to medical evaluation.
